Clinical Trial Update: A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

Phase 4 prospective trial evaluating cardio-renal outcomes of enavogliflozin in patients with type 2 diabetes mellitus; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Yonsei University | Conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases | Phase 4 | Status: RECRUITING